Search Results

Filter
  • 1-10 of  24 results for ""Receptors, Atrial Natriuretic Factor""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.

  • Authors : Shuhaibar LC; Department of Cell Biology, University of Connecticut Health Center, Farmington Connecticut, USA.; Kaci N

Subjects: Achondroplasia/Achondroplasia/Achondroplasia/*genetics ; Bone Development/Bone Development/Bone Development/*drug effects ; Enzyme Inhibitors/Enzyme Inhibitors/Enzyme Inhibitors/*pharmacology Acromesomelic dysplasia, Maroteaux type

  • Source: JCI insight [JCI Insight] 2021 May 10; Vol. 6 (9). Date of Electronic Publication: 2021 May 10.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

×
Academic Journal

Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism.

Subjects: Achondroplasia/Achondroplasia/Achondroplasia/*genetics ; Bone Development/Bone Development/Bone Development/*genetics ; Receptor, Fibroblast Growth Factor, Type 3/Receptor, Fibroblast Growth Factor, Type 3/Receptor, Fibroblast Growth Factor, Type 3/*genetics

  • Source: JCI insight [JCI Insight] 2021 May 10; Vol. 6 (9). Date of Electronic Publication: 2021 May 10.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

×
Academic Journal

C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness.

  • Authors : Michel K; Institute of Physiology, University of Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.

Subjects: Heart Failure/Heart Failure/Heart Failure/*drug therapy ; Myocardium/Myocardium/Myocardium/*metabolism ; Myocytes, Cardiac/Myocytes, Cardiac/Myocytes, Cardiac/*drug effects

  • Source: JCI insight [JCI Insight] 2020 Nov 19; Vol. 5 (22). Date of Electronic Publication: 2020 Nov 19.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

×
Academic Journal

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.

  • Authors : Engeli S; Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany.; Birkenfeld AL

Subjects: Oxidative Phosphorylation*; Atrial Natriuretic Factor/Atrial Natriuretic Factor/Atrial Natriuretic Factor/*physiology ; Muscle, Skeletal/Muscle, Skeletal/Muscle, Skeletal/*metabolism

  • Source: The Journal of clinical investigation [J Clin Invest] 2012 Dec; Vol. 122 (12), pp. 4675-9. Date of Electronic Publication: 2012 Nov 01.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.

  • Authors : Sabrane K; Institute of Pharmacology and Toxicology, University of Münster, Münster, Germany.; Kruse MN

Subjects: Atrial Natriuretic Factor/Atrial Natriuretic Factor/Atrial Natriuretic Factor/*metabolism ; Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*metabolism ; Guanylate Cyclase/Guanylate Cyclase/Guanylate Cyclase/*metabolism

  • Source: The Journal of clinical investigation [J Clin Invest] 2005 Jun; Vol. 115 (6), pp. 1666-74.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume.

  • Authors : Curry FR; Department of Physiology and Membrane Biology, School of Medicine, University of California Davis, Davis, California 95616, USA.

Subjects: Capillary Permeability/Capillary Permeability/Capillary Permeability/*physiology ; Extracellular Fluid/Extracellular Fluid/Extracellular Fluid/*metabolism ; Receptors, Atrial Natriuretic Factor/Receptors, Atrial Natriuretic Factor/Receptors, Atrial Natriuretic Factor/*metabolism

  • Source: The Journal of clinical investigation [J Clin Invest] 2005 Jun; Vol. 115 (6), pp. 1458-61.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.

  • Authors : Holtwick R; Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, Münster, Germany.; van Eickels M

Subjects: Atrial Natriuretic Factor/Atrial Natriuretic Factor/Atrial Natriuretic Factor/*metabolism ; Cardiomegaly/Cardiomegaly/Cardiomegaly/*metabolism ; Guanylate Cyclase/Guanylate Cyclase/Guanylate Cyclase/*metabolism

  • Source: The Journal of clinical investigation [J Clin Invest] 2003 May; Vol. 111 (9), pp. 1399-407.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury.

  • Authors : Izumi T; Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Saito Y

Subjects: Guanylate Cyclase/Guanylate Cyclase/Guanylate Cyclase/*antagonists & inhibitors ; Myocardial Ischemia/Myocardial Ischemia/Myocardial Ischemia/*prevention & control ; Myocardial Reperfusion Injury/Myocardial Reperfusion Injury/Myocardial Reperfusion Injury/*prevention & control

  • Source: The Journal of clinical investigation [J Clin Invest] 2001 Jul; Vol. 108 (2), pp. 203-13.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.

  • Authors : Tremblay J; Centre de Recherche Hôtel-Dieu de Montréal, Université de Montréal, Québec, Canada.; Huot C

Subjects: Gene Expression Regulation*; Atrial Natriuretic Factor/Atrial Natriuretic Factor/Atrial Natriuretic Factor/*metabolism ; Cyclic GMP/Cyclic GMP/Cyclic GMP/*biosynthesis

  • Source: The Journal of clinical investigation [J Clin Invest] 1993 Nov; Vol. 92 (5), pp. 2499-508.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

A friend within the heart: natriuretic peptide receptor signaling.

  • Authors : Molkentin JD; Department of Pediatrics, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA.

Subjects: Cardiomegaly/Cardiomegaly/Cardiomegaly/*metabolism ; Myocytes, Cardiac/Myocytes, Cardiac/Myocytes, Cardiac/*metabolism ; Receptors, Atrial Natriuretic Factor/Receptors, Atrial Natriuretic Factor/Receptors, Atrial Natriuretic Factor/*metabolism

  • Source: The Journal of clinical investigation [J Clin Invest] 2003 May; Vol. 111 (9), pp. 1275-7.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
  • 1-10 of  24 results for ""Receptors, Atrial Natriuretic Factor""